Business Context and Reporting Period
Promis Neurosciences Inc. (PMN), an emerging growth company incorporated in Ontario, Canada, filed this Form 8-K on July 5, 2024, regarding an event dated July 2, 2024. The company's common shares are listed on The Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on regulatory compliance status regarding listing standards.
Material Changes
On July 2, 2024, the company received written notice from Nasdaq stating it is not in compliance with Listing Rule 5550(b)(2). The non-compliance is due to the failure to maintain a minimum Market Value of Listed Securities (MVLS) of at least $35 million for the last 30 consecutive business days.
Outlook, Risks, and Management Commentary
- Compliance Period: The company has 180 calendar days from the notice date, until December 29, 2024, to regain compliance.
- Regaining Compliance: To comply, the MVLS must reach at least $35 million for a minimum of ten consecutive business days within the 180-day period.
- Delisting Risk: If compliance is not achieved by the deadline, the common stock will be subject to delisting.
- Appeal Rights: The company retains the right to appeal a delisting determination to a hearings panel if such a notice is received.
- Management Action: Management intends to monitor the market value and may consider available options to regain compliance, though there is no assurance of success.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities (MVLS) to assess proximity to the $35 million threshold.
- Monitor the stock price and trading volume over the next 180 days to track progress toward the 10-day compliance window.
- Review future filings for any announcements regarding capital raising or strategic actions intended to boost market value.
- Check for any subsequent Nasdaq communications regarding the extension of the compliance period or delisting proceedings.